These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29317129)

  • 21. Preimplantation genetic screening (PGS) is an excellent tool, but not perfect: a guide to counseling patients considering PGS.
    Brezina PR; Kutteh WH; Bailey AP; Ke RW
    Fertil Steril; 2016 Jan; 105(1):49-50. PubMed ID: 26493116
    [No Abstract]   [Full Text] [Related]  

  • 22. Pros and cons of implementing a carrier genetic test in an infertility practice.
    Gil-Arribas E; Herrer R; Serna J
    Curr Opin Obstet Gynecol; 2016 Jun; 28(3):172-7. PubMed ID: 27054511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolving role of genetics in reproductive medicine.
    Brezina PR; Kearns WG
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):41-55. PubMed ID: 24491983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory testing for preconception/prenatal carrier screening: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Guha S; Reddi HV; Aarabi M; DiStefano M; Wakeling E; Dungan JS; Gregg AR;
    Genet Med; 2024 Jul; 26(7):101137. PubMed ID: 38814327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Legal challenges in reproductive genetics.
    Suter SM
    Fertil Steril; 2021 Feb; 115(2):282-289. PubMed ID: 33579522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.
    Shapiro AJ; Kroener L; Quinn MM
    J Assist Reprod Genet; 2021 Apr; 38(4):957-963. PubMed ID: 33501564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic medicine in prenatal diagnosis.
    South ST; Chen Z; Brothman AR
    Clin Obstet Gynecol; 2008 Mar; 51(1):62-73. PubMed ID: 18303500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates.
    Peyser A; Singer T; Mullin C; Bristow SL; Gamma A; Onel K; Hershlag A
    Genet Med; 2019 Jun; 21(6):1400-1406. PubMed ID: 30327537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing indications for invasive testing in an era of improved screening.
    Norton ME; Rink BD
    Semin Perinatol; 2016 Feb; 40(1):56-66. PubMed ID: 26725145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction: Subchromosomal abnormalities in preimplantation embryonic aneuploidy screening.
    Scott RT
    Fertil Steril; 2017 Jan; 107(1):4-5. PubMed ID: 28040094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.
    Stevens B; Krstic N; Jones M; Murphy L; Hoskovec J
    Obstet Gynecol; 2017 Aug; 130(2):279-284. PubMed ID: 28697118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What are the required components of pre- and post-test counseling?
    Rink BD; Kuller JA
    Semin Perinatol; 2018 Aug; 42(5):287-289. PubMed ID: 30107889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The critical and expanding role of genetics in assisted reproduction.
    Kent-First M
    Prenat Diagn; 2000 Jul; 20(7):536-51. PubMed ID: 10913952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A closer look at expanded carrier screening from a PGD perspective.
    Vaz-de-Macedo C; Harper J
    Hum Reprod; 2017 Oct; 32(10):1951-1956. PubMed ID: 28938745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes.
    Capalbo A; Valero RA; Jimenez-Almazan J; Pardo PM; Fabiani M; Jiménez D; Simon C; Rodriguez JM
    PLoS Genet; 2019 Oct; 15(10):e1008409. PubMed ID: 31589614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of segmental aneuploidy and mosaicism in the human preimplantation embryo: technical considerations and limitations.
    Treff NR; Franasiak JM
    Fertil Steril; 2017 Jan; 107(1):27-31. PubMed ID: 27816233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of cell-free DNA screening is associated with changes in prenatal genetic counseling indications.
    Stevens BK; Noblin SJ; Chen HY; Czerwinski J; Friel LA; Wagner C
    J Genet Couns; 2019 Jun; 28(3):692-699. PubMed ID: 30791172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.